常染色体显性多囊肾病:影像学在诊断与管理中的作用
本文阐述常染色体显性多囊肾病(ADPKD)的影像诊断与危险分层:主要依据US的年龄依赖标准及可见囊肿数目诊断,按Mayo Clinic影像分类(MCIC)分为典型1类与非典型2类,1类再按身高校正总肾体积分为A-E五型;身高校正TKV可预测肾功能下降与肾衰竭,MCIC 1C-E型进展为终末期肾病风险高、可能受益于血管加压素受体拮抗剂;放射科医生在诊断、排除 mimic、识别并发症、评估严重程度及预测肾衰竭中居核心地位,介入放射科医生通过囊肿引流、硬化治疗或栓塞参与并发症治疗。
要点
- ADPKD诊断通常基于US的年龄依赖标准及可见囊肿数目。
- 按MCIC分为典型1类与非典型2类,1类再按身高校正TKV分为A-E五型。
- 身高校正TKV越大(即MCIC 1C-E)进展为终末期肾病风险高,可能受益于血管加压素受体拮抗剂。
核心结论
- ADPKD诊断通常在影像上确立、主要依据US的年龄依赖标准及可见囊肿数目;MCIC将ADPKD分为典型1类与非典型2类,1类再按身高校正TKV分为A-E五型;身高校正TKV可预测未来肾功能下降与肾衰竭,MCIC 1C-E型进展为终末期肾病风险高、可能受益于血管加压素受体拮抗剂;放射科医生在诊断、排除 mimic、识别并发症、评估严重程度及预测肾衰竭中居核心地位,介入放射科医生通过囊肿引流、硬化治疗或栓塞治疗并发症。
研究设计与样本
- 本文为发表于Radiographics的综述,检索范围与纳入文献数原文未报告。
- 原文未报告样本量、中心数及参考标准。
关键影像表现/征象
- ADPKD诊断主要依据US所见囊肿数目及年龄依赖标准。
- 按MCIC分为典型1类与非典型2类,1类再按身高校正TKV分为A-E五型。
- 身高校正TKV越大(即MCIC 1C-E)进展为终末期肾病风险高。
- 怀疑恶性复杂囊肿时减影图像是关键,因蛋白和血液可限制对强化成分的评估。
- 其他肾脏并发症主要与囊肿内出血或囊肿感染有关。
诊断标准与关键数值
- ADPKD诊断基于年龄依赖标准及可见囊肿数目,通常在US上确立。
- MCIC将ADPKD分为1类(典型)与2类(非典型);MCIC 1类再按身高校正TKV分为A、B、C、D、E五型。
- MCIC 1C-E型身高校正TKV较大,进展为终末期肾病风险高。
- 多种方法可用于估算身高校正TKV。
临床应用与阅片要点
- 放射科医生在确立诊断、排除 mimic、识别并发症、评估严重程度及预测未来肾衰竭中居核心地位。
- 怀疑恶性复杂囊肿时应使用减影图像评估强化成分,因蛋白和血液可限制评估。
- 介入放射科医生通过囊肿引流、硬化治疗或栓塞参与并发症治疗。
- MCIC 1C-E型进展为终末期肾病风险高,可能受益于血管加压素受体拮抗剂,后者已显示可减小囊肿生长速率并减缓肾功能下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic kidney disorder with progressive renal function decline, and disease severity is determined based on the type of genetic mutation. The diagnosis is usually established at imaging, primarily at US, and is based on age-dependent criteria and the number of visible cysts. ADPKD is classified into class 1 (typical) and class 2 (atypical) according to the Mayo Clinic Imaging Classification (MCIC) system. Height-adjusted total kidney volume (TKV) has emerged as a predictor of future renal function decline and renal failure in ADPKD, and several methods can be used for estimation. MCIC class 1 ADPKD is further subdivided into five types based on height-adjusted TKV (A, B, C, D, and E). Patients with a larger height-adjusted TKV (ie, MCIC 1C-E) are at high risk for progression to end-stage renal disease and will potentially benefit from vasopressin receptor antagonists, which have been shown to reduce the rate of cyst growth and slow renal function decline. Other renal complications primarily relate to hemorrhage within cysts or cyst infections. Subtraction images are key for assessment of complex cysts when malignancy is suspected, as the presence of protein and blood can limit the assessment for an enhancing component. The radiologist has a central role in establishing a diagnosis, excluding mimics, identifying complications, assessing severity, and predicting future renal failure. Interventional radiologists play a therapeutic role in management of complications by cyst drainage, sclerotherapy, or embolization. © RSNA, 2022 Online supplemental material and the slide presentation from the RSNA Annual Meeting are available for this article.
引用
- Odedra D, Sabongui S, Khalili K, et al. Autosomal Dominant Polycystic Kidney Disease: Role of Imaging in Diagnosis and Management. Radiographics. 2023. PMID: 36459494. doi:10.1148/rg.220126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。